CD8a, Fc Fusion, Avi-Tag, HiP™ Recombinant

CD8a, Fc Fusion, Avi-Tag, HiP™ Recombinant
SKU
BPS101870-2
Packaging Unit
100 µg
Manufacturer
BPS Bioscience

Availability: loading...
Price is loading...
Products from BPS Bioscience require a minimum order value above 400€

Encompassing Amino Acids: 22-182

Background: CD8 is a co-receptor for the TCR (T cell receptor) in T cells, binding to MHC (major histocompatibility complex) class I proteins. CD8 is a typical marker of cytotoxic T cells and is involved in signaling. CD8 has two isoforms, a and b. CD8b recruits Lck (lymphocyte-specific protein tyrosine kinase) to the TCR-CD3 complex, and Lck phosphorylates multiple proteins involved in activation of cytotoxic T lymphocytes. It is thus critical for the lysis of cancer cells.

Description: Recombinant human CD8a (cluster of differentiation 8 a) transcript 1 encompassing amino acids 22-182. This construct contains a C-terminal Fc domain followed by an Avi-Tag™. The recombinant protein was affinity purified. HiP™ indicates a high purity protein (≥90% pure) with less than 10% aggregation as measured by gel filtration.

Format: Aqueous buffer solution

Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

Genbank: NM_001768.7

Host Cell Line: HEK293

Purity: ≥90%

Storage Stability: At least 6 months at -80°C.

Tags: C-terminal FC, C-terminal Avi-Tag™

Uniprot: P01732

Warnings: Avoid freeze/thaw cycles

Biosafety Level: Not applicable (BSL-1)
More Information
SKU BPS101870-2
Manufacturer BPS Bioscience
Manufacturer SKU 101870-2
Package Unit 100 µg
Quantity Unit STK
Host Human
Product information (PDF) Download
MSDS (PDF)
×